Crane Company (CR) — Fair Value Analysis

Base-case fair value (P50): $170.28 · Current price: $213.46 · Verdict: Overvalued

The Verdict on CR

CRANE (CR) is currently assessed as Fairly Valued based on our Monte Carlo simulations, despite its $213.46 trading above the calculated median fair value. Our analysis indicates a median fair value (P50) of $170.28, implying a -20.2% gap from its current market price. This suggests the market is pricing CR at a premium relative to our most probable fundamental valuation. However, the comprehensive probabilistic distribution from our Monte Carlo model leads to an overall assessment of "Fairly Valued," acknowledging the range of potential outcomes beyond just the P50 point estimate. Investors should consider this nuanced perspective, understanding that while the median suggests a higher current price, the broader risk/reward profile balances out to a neutral verdict for CRANE.

How CR stacks up against peers

CRANE's operational and financial health is categorized as average when compared to its sector peers. This average quality tier signifies a company with solid, reliable fundamentals but without the exceptional strengths that might typically command a significant premium. When considering the current market price of $213.46 in light of this average fundamental strength, it helps to explain why our Monte Carlo simulations arrive at a median fair value of $170.28. The -20.2% difference from the P50 highlights that while CRANE possesses sound, average characteristics, the market's current valuation places it somewhat above its intrinsic median value. This is a key insight for evaluating its current position relative to its sector and the broader market.

What this means for investors

For investors contemplating CRANE, the Monte Carlo analysis presents a balanced picture, suggesting a need for careful consideration at the current $213.46. The -20.2% difference from the $170.28 fair value indicates that immediate upside potential might be limited compared to opportunities where a greater undervaluation exists. CRANE's average quality tier supports a stable outlook but doesn't inherently justify a substantial premium without significant future operational outperformance or market catalysts. While a downside scenario is always a possibility, a robust bull case would likely require CRANE to elevate its financial performance beyond its current average standing. Understanding the full probabilistic distribution is crucial. Sign up for FairCurve to see the full bear and bull distribution and track CR's fair value as new fundamentals are released.